| scholarly article | Q13442814 |
| P50 | author | Junfei Jin | Q57033868 |
| P2093 | author name string | Songqing He | |
| Qun Zhu | |||
| Biao Lei | |||
| Syed Abdul Tahir | |||
| Wuxiang Shi | |||
| Weijia Liao | |||
| Shengguang Yuan | |||
| Jingmei Zhang | |||
| Wenmin Yao | |||
| Liling Qin | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma | Q31111026 | ||
| Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma | Q33903701 | ||
| Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation | Q34038193 | ||
| HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer | Q34056283 | ||
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
| Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma. | Q34289623 | ||
| Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. | Q34806672 | ||
| Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients | Q35597216 | ||
| Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. | Q36052307 | ||
| Resection and liver transplantation for hepatocellular carcinoma. | Q36140302 | ||
| Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma | Q36299107 | ||
| The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma | Q36353298 | ||
| Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients | Q36663605 | ||
| Advanced hepatocellular carcinoma: which staging systems best predict prognosis? | Q36836103 | ||
| Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. | Q37040624 | ||
| Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms | Q38354220 | ||
| Major causes of death among men and women in China | Q39061262 | ||
| Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells | Q39200506 | ||
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients | Q39805787 | ||
| Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients | Q41259916 | ||
| Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib | Q43411812 | ||
| Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China | Q43587535 | ||
| Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. | Q43725941 | ||
| Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence | Q44391422 | ||
| Predictors and patterns of recurrence after resection of hepatocellular carcinoma | Q44636627 | ||
| Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy | Q44638336 | ||
| Predictors of survival after resection of early hepatocellular carcinoma | Q44891392 | ||
| Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. | Q45962190 | ||
| The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. | Q46634652 | ||
| A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. | Q50753723 | ||
| Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. | Q51029484 | ||
| High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. | Q51536892 | ||
| Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. | Q53244866 | ||
| Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers | Q56985475 | ||
| Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients | Q79450701 | ||
| Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma | Q79761884 | ||
| Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome | Q81934952 | ||
| Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma | Q82824387 | ||
| Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma | Q84136130 | ||
| A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System | Q84184317 | ||
| Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge | Q84598404 | ||
| Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer | Q84990039 | ||
| Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study | Q85026135 | ||
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 248-255 | |
| P577 | publication date | 2014-03-04 | |
| P1433 | published in | Translational Oncology | Q26839583 |
| P1476 | title | Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection | |
| P478 | volume | 7 |
| Q37124765 | Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy |
| Q24658602 | Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis |
| Q39093002 | Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy |
| Q94475962 | Correlation between the expressions of circular RNAs in peripheral venous blood and clinicopathological features in hepatocellular carcinoma |
| Q91639547 | Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus |
| Q40347780 | HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus. |
| Q35767923 | High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma |
| Q50494487 | Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection. |
| Q39464688 | Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas |
| Q38972296 | Neutrophil extracellular traps sequester circulating tumor cells via β1-integrin mediated interactions |
| Q35220302 | Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer |
| Q33762053 | Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis |
| Q36052780 | Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies |
| Q59335194 | Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma |
| Q58759153 | Outcomes of anterior approach major hepatectomy with diaphragmatic resection for single huge right lobe HCC with diaphragmatic invasion |
| Q37725550 | Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy |
| Q89884064 | Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy |
| Q52604610 | Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy. |
| Q36567016 | Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma |
| Q58759051 | Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection |
| Q53484321 | Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. |
| Q37669512 | Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection |
| Q39552999 | Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis |
| Q55259541 | Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country. |
| Q36019935 | Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report. |
| Q50195636 | Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma |
| Q36824972 | Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy |
| Q85855456 | Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer |
| Q33652003 | Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis |
| Q36905681 | Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection. |
| Q36544083 | TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells |
| Q47243940 | The Value of the C-Reactive Protein-to-Albumin Ratio is Useful for Predicting Survival of Patients with Child-Pugh Class A Undergoing Liver Resection for Hepatocellular Carcinoma |
| Q48350251 | The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis. |
| Q92006441 | The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma |
| Q90008725 | Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio |
| Q36414399 | Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma |
| Q60932844 | Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma |
Search more.